Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

214studies shown

Showing 145-156 of 214

Drug study icon

Active Not RecruitingNCT06442462

SPG302 in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Australia
Sponsor: Spinogenix
Condition: Schizophrenia

Drug study icon

CompletedNCT01072630

Armodafinil Treatment for depression

This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.

In Australia

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Australia, France, ...
Sponsor: Cephalon
Condition: Bipolarity, Depression

Other study type icon

CompletedNCT05860959

SUBLOCADE Long-term Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

AddictionObservationalOver 18 Years

Countries: United States, Australia, Canada, ...
Sponsor: Indivior Inc.
Condition: Addiction

Other study type icon

Active Not RecruitingNCT03944798

Surveillance AFter Extremity Tumor surgerY

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

AnxietyOtherOver 18 Years

Countries: United States, Australia, Canada, ...
Sponsor: McMaster University
Condition: Anxiety

Drug study icon

TerminatedNCT03897062

Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

AddictionDrugFrom 18 Years to 75 Years

Countries: Australia
Sponsor: The Florey Institute of Neuroscience and Mental Health
Condition: Addiction

Device study icon

CompletedNCT01733602

tDCS to Enhance Cognitive Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDeviceFrom 18 Years to 65 Years

Countries: Australia
Sponsor: The University of New South Wales
Condition: Schizophrenia

Behavioral study icon

Active Not RecruitingNCT05528302

Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

AnxietyBehavioralOver 18 Years

Countries: Australia
Sponsor: The University of Queensland
Condition: Anxiety

Behavioral study icon

CompletedNCT05030285

Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AnxietyBehavioral

Countries: Australia
Sponsor: The University of Queensland
Condition: Anxiety

Drug study icon

CompletedNCT05253417

The CANabidiol Use for RElief of Short Term Insomnia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

AnxietyDrugFrom 18 Years to 65 Years

Countries: Australia
Sponsor: Bod Australia
Condition: Anxiety

Behavioral study icon

CompletedNCT05402657

The RAFT ECT Study

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

DepressionBehavioralOver 18 Years

Countries: United States, Australia
Sponsor: The George Institute
Condition: Depression

Other study type icon

TerminatedISRCTN00982930

The shareIT project

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

In Australia

DepressionOtherOver 18 Years

Countries: Australia
Sponsor: Australian National University (Australia)
Condition: Depression

Behavioral study icon

CompletedNCT02751632

The Staged Treatment in Early Psychosis Study

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaBehavioralFrom 12 Years to 25 Years

Countries: Australia
Sponsor: Orygen
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.